149 related articles for article (PubMed ID: 28695481)
1. A Novel Rat Model of Nonalcoholic Fatty Liver Disease Constructed Through CRISPR/Cas-Based Hydrodynamic Injection.
Yu Q; Tan RZ; Gan Q; Zhong X; Wang YQ; Zhou J; Wang L
Mol Biotechnol; 2017 Oct; 59(9-10):365-373. PubMed ID: 28695481
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-based Pten knock-out and Sleeping Beauty Transposon-mediated Nras knock-in induces hepatocellular carcinoma and hepatic lipid accumulation in mice.
Gao M; Liu D
Cancer Biol Ther; 2017 Jul; 18(7):505-512. PubMed ID: 28513320
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-mediated direct mutation of cancer genes in the mouse liver.
Xue W; Chen S; Yin H; Tammela T; Papagiannakopoulos T; Joshi NS; Cai W; Yang G; Bronson R; Crowley DG; Zhang F; Anderson DG; Sharp PA; Jacks T
Nature; 2014 Oct; 514(7522):380-4. PubMed ID: 25119044
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Editing of the Adult Mouse Liver Using CRISPR/Cas9 and Hydrodynamic Tail Vein Injection.
Niola F; Dagnæs-Hansen F; Frödin M
Methods Mol Biol; 2019; 1961():329-341. PubMed ID: 30912055
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses.
Wang D; Mou H; Li S; Li Y; Hough S; Tran K; Li J; Yin H; Anderson DG; Sontheimer EJ; Weng Z; Gao G; Xue W
Hum Gene Ther; 2015 Jul; 26(7):432-42. PubMed ID: 26086867
[TBL] [Abstract][Full Text] [Related]
6. [Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats].
Xu YJ; Yang QH; Han L; Zhang YP; Liu YZ; Jin L; Yan HZ
Zhong Yao Cai; 2014 Jan; 37(1):80-6. PubMed ID: 25090711
[TBL] [Abstract][Full Text] [Related]
7. Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing.
Pankowicz FP; Barzi M; Kim KH; Legras X; Martins CS; Wooton-Kee CR; Lagor WR; Marini JC; Elsea SH; Bissig-Choisat B; Moore DD; Bissig KD
Gastroenterology; 2018 Dec; 155(6):1967-1970.e6. PubMed ID: 30170115
[TBL] [Abstract][Full Text] [Related]
8. Reduced hepatic lipid content in Pten-haplodeficient mice because of enhanced AKT2/PKBβ activation in skeletal muscle.
Schultze SM; Dietrich M; Hynx D; Geier A; Niessen M; Spinas GA; Hemmings BA; Tschopp O
Liver Int; 2015 Apr; 35(4):1354-66. PubMed ID: 24845341
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated deletion of adipocyte genes associated with NAFLD alters adipocyte lipid handling and reduces steatosis in hepatocytes in vitro.
Lopez-Yus M; Frendo-Cumbo S; Del Moral-Bergos R; Garcia-Sobreviela MP; Bernal-Monterde V; Rydén M; Lorente-Cebrian S; Arbones-Mainar JM
Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1178-C1189. PubMed ID: 37721003
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.
Liu Y; Qi X; Zeng Z; Wang L; Wang J; Zhang T; Xu Q; Shen C; Zhou G; Yang S; Chen X; Lu F
Sci Rep; 2017 Jun; 7(1):2796. PubMed ID: 28584302
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing.
Moses C; Hodgetts SI; Nugent F; Ben-Ary G; Park KK; Blancafort P; Harvey AR
Sci Rep; 2020 Jul; 10(1):11393. PubMed ID: 32647121
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease progression in rats is accelerated by splenic regulation of liver PTEN/AKT.
Wang Z; Li N; Wang B; Lin J
Saudi J Gastroenterol; 2015; 21(4):232-8. PubMed ID: 26228367
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway.
Han J; He Y; Zhao H; Xu X
J Cell Biochem; 2019 Sep; 120(9):14735-14744. PubMed ID: 31009107
[TBL] [Abstract][Full Text] [Related]
14. Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide.
Van Herck MA; Vonghia L; Francque SM
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953222
[TBL] [Abstract][Full Text] [Related]
15. Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using "Good-Fit" Genome-Editing Tools.
Kim U; Kim N; Shin HY
Cells; 2020 Dec; 9(12):. PubMed ID: 33271878
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice.
Huai C; Jia C; Sun R; Xu P; Min T; Wang Q; Zheng C; Chen H; Lu D
Hum Genet; 2017 Jul; 136(7):875-883. PubMed ID: 28508290
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
[TBL] [Abstract][Full Text] [Related]
18. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
[TBL] [Abstract][Full Text] [Related]
19. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
Tan DY; Shi HY; Li CP; Zhong XL; Kang M
World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
[TBL] [Abstract][Full Text] [Related]
20. Leptin improves fatty liver independently of insulin sensitization and appetite suppression in hepatocyte-specific Pten-deficient mice with insulin hypersensitivity.
Yamamoto-Kataoka S; Ebihara K; Aizawa-Abe M; Nishio M; Kusakabe T; Yamamoto Y; Aotani D; Sakai T; Zhao M; Ebihara C; Gumbilai VM; Hosoda K; Suzuki A; Nakao K
Horm Metab Res; 2015 Mar; 47(3):168-75. PubMed ID: 25415231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
